JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Irwin, M.
Right arrow Articles by Britton, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Irwin, M.
Right arrow Articles by Britton, K. T.

Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity

M Irwin, RL Hauger, L Jones, M Provencio and KT Britton

Department of Psychiatry, San Diego Veterans Administration Medical Center, California.

Corticotropin-releasing factor (CRF) acts within the brain to elicit changes in neuroendocrine, autonomic and behavioral activity similar to those observed after stress. A reduction of cellular immune function as measured by splenic natural killer cell activity has also been described following the central administration of CRF. In this study we evaluated the role of the sympathetic nervous system in mediating CRF- induced suppression of natural killer (NK) cytotoxicity. Synthetic rat CRF (1.0 microgram) microinjected into the lateral ventricle increased noradrenergic function and reduced NK activity in the rat spleen. Pretreatment of the animals by chemical sympathectomy (6-hydroxy- dopamine, 100 mg/kg i.p. daily over 10 days) produced a greater than 95% reduction of splenic norepinephrine concentration and abolished completely both the CRF-induced increase in plasma catecholamine levels and the reduction in splenic NK activity. In addition, beta adrenergic receptor blockade (either propranolol, 10 mg/kg i.p., or butoxamine, 25 mg/kg i.p. 30 min before i.c.v. infusion) antagonized the CRF-induced reduction in NK activity. Measurement of circulating levels of adrenocorticotrophic hormone and corticosterone demonstrated that activation of the pituitary adrenal axis by CRF was dissociated from changes in NK activity. These findings suggest that the sympathetic nervous system mediates the suppression of splenic NK cytotoxicity after i.c.v. CRF.

Volume 255, Issue 1, pp. 101-107, 10/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
M. Irwin, J. Pike, and M. Oxman
Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment
Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. D'Arbe, R. Einstein, and N. A. Lavidis
Stressful animal housing conditions and their potential effect on sympathetic neurotransmission in mice
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1422 - R1428.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. K. Dishman, J. M. Warren, S. Hong, B. N. Bunnell, E. H. Mougey, J. L. Meyerhoff, L. Jaso-Friedmann, and D. L. Evans
Treadmill exercise training blunts suppression of splenic natural killer cell cytolysis after footshock
J Appl Physiol, June 1, 2000; 88(6): 2176 - 2182.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Chen and S. Reichlin
Mechanisms by Which Blood Levels of Interleukin-6 (IL-6) Are Elevated after Intracerebroventricular Injection of IL-1{beta} in the Rat: Neural Versus Humoral Control
Endocrinology, December 1, 1999; 140(12): 5549 - 5555.
[Abstract] [Full Text]


Home page
NEJMHome page
S. Reichlin
Neuroendocrine-Immune Interactions
N. Engl. J. Med., October 21, 1993; 329(17): 1246 - 1253.
[Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.